Leadsynbio was established in 2015 with a focus on cutting-edge research in the field of synthetic biology. It is involved in the development, production, and marketing of industrial biotechnologies for the pharmaceutical, food, and health care industries as well as animal health products, with the goal of providing sustainable ingredients made with synthetic biology.

At present, the company has a variety of products in its pipeline, including a series of products such as D-ethyl ester,(a veterinary antibiotic florfenicol intermediate), high-end feed additive active vitamin D3, and NMN(a new anti-aging molecule) .